Literature DB >> 22415179

[Hepatitis B mortality in Brazil, 2000-2009].

Márcia de Cantuária Tauil1, Thiago Rodrigues de Amorim, Gerson Fernando Mendes Pereira, Wildo Navegantes de Araújo.   

Abstract

This descriptive study focused on the mortality profile associated with hepatitis B virus (HBV) in Brazil as a whole and by region, based on data from the Mortality Information System (MIS). The study sample consisted of deaths from HBV recorded in the MIS from January 1, 2000, to December 31, 2009. The crude mortality rate remained constant in the country; the proportion of hepatocellular carcinoma with HBV as the associated cause was no greater than 7%. The standardized mortality rate was highest in the North of Brazil, and the proportional mortality rate was higher in males. In 2009, the potential years of life lost (PYLL) were highest in males in the 50-59-year age bracket and in females in the 40-49-year bracket. The largest increase in PYLL occurred in males 60 to 69 years of age. The study emphasizes the importance of scaling up preventive measures against HBV, in addition to expanding access to early diagnosis in order to reduce HBV mortality in the coming decades.

Entities:  

Mesh:

Year:  2012        PMID: 22415179     DOI: 10.1590/s0102-311x2012000300007

Source DB:  PubMed          Journal:  Cad Saude Publica        ISSN: 0102-311X            Impact factor:   1.632


  3 in total

1.  Assessment of Adherence to Prescribed Therapy in Patients with Chronic Hepatitis B.

Authors:  Rodrigo Martins Abreu; Camila da Silva Ferreira; Aline Siqueira Ferreira; Eduardo Remor; Paulo Dominguez Nasser; Flair José Carrilho; Suzane Kioko Ono
Journal:  Infect Dis Ther       Date:  2016-01-13

2.  Mortality and potential years of life lost by road traffic injuries in Brazil, 2013.

Authors:  Silvânia Suely Caribé de Araújo Andrade; Maria Helena Prado de Mello-Jorge
Journal:  Rev Saude Publica       Date:  2016-10-03       Impact factor: 2.106

3.  Mortality trend due to Hepatitis B and C in the city of São Paulo, 2002-2016.

Authors:  Ana Paula Sayuri Sato; Inês Kazue Koizumi; Norma Suely de Oliveira Farias; Célia Regina Ciccolo da Silva; Maria Regina Alves Cardoso; Gerusa Maria Figueiredo
Journal:  Rev Saude Publica       Date:  2020-12-04       Impact factor: 2.106

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.